4.6 Review

The role of SRc-3 in human breast cancer

期刊

NATURE REVIEWS CLINICAL ONCOLOGY
卷 7, 期 2, 页码 83-89

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nrclinonc.2009.219

关键词

-

类别

资金

  1. Cancer Reasearch UK
  2. Ministry of Education of the Czech Republic [MSM 0021620808]
  3. European Society of Medical Oncology
  4. Cancer Research UK
  5. Department of Health
  6. Cancer Research UK [12011] Funding Source: researchfish

向作者/读者索取更多资源

Members of the nuclear receptor superfamily are ligand-regulated transcription factors involved in the control of a broad range of normal physiological and disease processes. The estrogen receptor alpha (ER alpha) is a member of the steriod receptor family, which is part of the nuclear receptor superfamily. ER alpha it is important for many biological processes and plays a key role in the pathogenesis of breast cancer. Gene regulation by ER alpha requires the recruitment of a multitude of transcriptional co-regulators to the promoters of estrogen-responsive genes. There is evidence in support of the involvement of these co-regulators in breast cancer progression. We review the role of steroid receptor co-activator-3 (SRC-3), which is frequently amplified in breast cancer, and its role in breast cancer risk, outcome and response to endocrine therapy in patients with breast cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据